WebJan 20, 2024 · Psychedelic-focused drug company Eleusis is merging with Silver Spike Acquisition Corp. II, a special purposes acquisition company, and heading to the Nasdaq with a combined enterprise value of $446 million.. London-based Eleusis is a pioneer in the development of psychedelic drug candidates. The company’s lead asset, ELE-Psilo, is … WebJun 18, 2024 · The shares closed up nearly 30% to $19.45 each. The German biotech’s initial public offering was priced Thursday night at $15 per share, the high end of the expected …
How to Invest in Psychedelics, 43-Year-Old German Billionaire …
WebJun 22, 2024 · Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. Here are five of the top drug … WebAug 23, 2024 · The top Biotechnology funds have $500 million to over a billion in assets under management– more than five times what most of the psychedelic funds have. The psychedelic-focused funds do offer an important opportunity for psychedelic biotech companies to find investors that understand their needs, but tapping into the greater … nine of swords and queen of swords
Center for the Neuroscience of Psychedelics
WebMay 9, 2024 · After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in … WebSep 19, 2024 · Mind Medicine is a psychedelic medicine and biotech company that discovers, develops and deploys psychedelics-inspired medicines and therapies to address addiction and mental illness. Mindset ... WebFeb 12, 2024 · And on Thursday a group of mid-tier VCs (and a group of angels) announced an investment of $11.5 million in a small biotech company called Mindstate Design Labs, which is creating therapy drugs... nine of swords horovisor